As the year winds down, take the opportunity to evaluate, refine, and set the stage for your 2025 planning. ?? Set yourself up for success by fully grasping your needs for 2025! ?? Is there a good match between your needs and the expertise in your organization? ?? Have you looked into the advantages of Fractional Management? Finish 2024 strong and set your organization up for an even better 2025! What’s on your radar as the year wraps up? We’d love to hear! Jovan Antunovic #planning #2025success #fractionalmanagement
STRAT2TACT Consulting
商务咨询服务
Montreal,QC 295 位关注者
Healthcare FRACTIONAL Commercialization Partner. Better Decisions. Better Outcomes.
关于我们
Welcome to STRAT2TACT Consulting (www.strat2tact.com). Better Decisions. Better Outcomes. Your healthcare commercialization partner for biopharma, biotech, medical device and medical technology comes with 25+ years’ experience in the U.S., Canada, Europe and Japan. STRAT2TACT Consulting provides FRACTIONAL SUPPORT for: 1) Commercialization; and 2) start-up operations The STRAT2TACT service offering covers Marketing, Sales, Access/Reimbursement, Patient Advocacy, Patient Support Programs, Medical Affairs, Distribution / Procurement, Regulatory, Legal and Human Resources.
- 网站
-
www.strat2tact.com
STRAT2TACT Consulting的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 2-10 人
- 总部
- Montreal,QC
- 类型
- 私人持股
- 创立
- 2024
- 领域
- Biotech、Pharmaceutical、Biopharma、Pharmaceutical、Medical Device、Strategic Planning、Tactical Planning、General Management、Start-Up、Access、Patient Support、Advocacy、Marketing 、Sales 、Medical、Sales Operations、Distribution、Business Planning和Execution
地点
-
主要
CA,QC,Montreal
动态
-
Last week I hosted a webinar on ?? #Launching Your #Biopharma Country #Affiliate in collaboration with #phraktion's Peer-to-Peer webinar series, featuring #pharma industry leaders. We explored key initial choices crucial for your affiliate's direction, aiming to spark productive discussions and debates for your venture's success. In case you missed it, the webinar has been dissected into key sections with timings for your convenience: - Agenda and Objectives: 5:35 to 7:32 - Key Considerations pre-and-post launch: 7:35 to 10:48 - #SuccessRoadmap: 11:00 to 16:38 - #Fractional vs. #Fulltime: 16:39 to 22:09 - Q&A (engaging discussion): 22:10 to 43:44 Catch the insightful webinar recording on the #phraktion YouTube channel: https://lnkd.in/eneCawAW Enjoy and if you would like to discuss more you can email me at [email protected]
P2P Webinar 19/9/24: Launching Your Biopharma Country Affiliate
https://www.youtube.com/
-
STRAT2TACT Consulting is excited to announce strategic partnerships with psphere, Toc Toc Communications, hashtag #CreativeResearchDesigns, hashtag #HumanCapitalManagement and NorthStar Advisors. These collaborations are set to enhance our service offerings and provide exceptional value to our clients in the United States and Canada. A big thank you to Kristen Hogan, RN, BScN Arnaud Lavenue Barbara McGrath Elsa Rolo and Dan Zavodnick, JD for taking this step with STRAT2TACT Consulting. With over 25 years of experience in healthcare commercialization, STRAT2TACT Consulting specializes in biopharma, biotech, medical devices, and medical technology. Our fractional support services include hashtag #commercialization #startupoperations #advising #VentureCapital #PrivateEquity . For more details on how our expanded services can benefit your organization, reach out to Jovan Antunovic, our Managing Director, at +1-514-909-6807 or [email protected]. https://lnkd.in/eRNUahfi
-
A perspective on effective decision-making. https://lnkd.in/eZt8VQJb
Fractional Commercialization Leader | Propel Biotech, Biopharma, Med Device & Med Tech Innovations to Market Leadership
As we approach the end of the year, it's crucial to consider different approaches to #Effective #DecisionMaking. Having utilized two distinct methods in the past, now is an opportune time to implement these strategies for pending projects or to allocate surplus funds wisely. #YearEndDecisions #StrategicPlanning #strat2tact
Effective Decision-Making: Two Approaches
Jovan Antunovic,发布于领英
-
After a well-deserved break, I am thrilled to be back and fully focused on maximizing the opportunities that #2024 has in store. This year has brought its share of challenges, victories, and diverse experiences. As we near the year's end, my determination to finish strong has never been stronger. With just over 4 months left in #2024, I am eager to build on our progress and drive even greater impact. Whether it involves completing existing projects, launching new endeavors, or exploring fresh solutions, I am prepared to engage wholeheartedly. The final months of the year are pivotal for planning the upcoming business year. I am excited to engage with my network, exchange insights, and offer support where needed. Let's ensure that these remaining months are exceptionally productive! How are you gearing up for the end of the year? I am keen to hear about your strategies and outlook as we strive towards our shared goals. For further discussions, feel free to reach out to me at +1-514-909-6807 or via email at [email protected]. www.strat2tact.com
strat2tact
strat2tact.com
-
The end of an era marks the beginning of a new chapter as Skyrizi is set to surpass Humira as AbbVie's leading revenue generator. Stay up-to-date with latest insights: https://lnkd.in/eq-g_xFM #Humira #Skyrizi
Skyrizi poised to overtake Humira as AbbVie's top earner
ml.firstwordpharma.com
-
Let's discuss the real meaning of fraction(al)! #FractionalManagement #BusinessConsulting #PartTimeExecutives #BusinessFlexibility #ExecutiveConsultants #SmallBusinessSolutions #ExpertAdvice #CorporateStrategy #ProfessionalServices #STRAT2TACT #FractionalConsultants #ProjectManagement #BusinessStrategy
The "real" meaning of fraction(al)
STRAT2TACT Consulting,发布于领英
-
Very interesting but not surprising about biosimilar penetration in the U.S. Better performance in oncology and ophthalmology than in immunology indications. Will this trend be maintained? Time will tell. #biosimilars #biologics #US https://lnkd.in/e6TrT4j4
Samsung report shows biosimilars struggle in immunology, succeed in oncology
ml.firstwordpharma.com
-
STRAT2TACT Consulting is now a proud "NETWORK" member of @CQDM. Excited to play a role in showcasing #Québec as a prominent global player in #biotechnology and #lifesciences. #biotech #biopharma #strat2tact #strategy #betterdecisions #betteroutcomes #CQDM. Visit www.strat2tact.com for more information! ?? #networking #biotechindustry #lifesciencesindustry
strat2tact
strat2tact.com
-
The researchers found that when neurologists and neuro-radiologists used the tool with their own assessments, it increased their accuracy in diagnosing all 10 types of dementia by more than 26% compared to when they worked without the tool. Using 100 random cases, 12 neurologists were asked to diagnose each case and provide a confidence score ranging from zero to 100. The scores were then averaged with the probability scores generated by the AI tool to calculate an AI-augmented neurologist score. My biggest concern is what happens after - is our healthcare system ready for this influx of patients that may develop a type of dementia down the road. Interested to hear what everyone else thinks. #dementia #AI #thefutureofmedicine https://lnkd.in/esxWu8qu
New genAI tool can accurately diagnose 10 different types of dementia: study
ml.firstwordhealthtech.com